17-07-2025
File affidavit detailing NAT-PCR rollout in blood collection centres: HC to govt
1
2
Cuttack: Orissa High Court on Thursday directed the state's health and family welfare department to file an affidavit within two weeks detailing the steps taken to implement Nucleic Acid Testing Polymerase Chain Reaction (NAT-PCR) blood testing facilities in all govt-run blood collection centres.
The directive came after a petition was filed by advocate Prabir Kumar Das.
A division bench comprising Chief Justice Harish Tandon and Justice M S Raman passed the order while hearing the petition, which sought contempt proceedings against the commissioner-cum-secretary of the health and family welfare department for allegedly failing to comply with the court's earlier directive issued on Nov 30, 2023.
The court had, at the time, disposed a PIL filed by Das calling for the introduction of advanced NAT-PCR testing in all blood banks, citing that the method allows for earlier detection of HIV 1 & 2, and Hepatitis B and C, compared to the traditional ELISA test.
In its 2023 affidavit, the state govt had informed the court that 47% of the state's blood collections were already being tested via NAT-PCR at 11 centres and that it had decided, in principle, to extend the facility to the remaining 45 centres by March 2025 at a cost of Rs 200 crore.
However, in his contempt plea filed on April 2 this year, Das submitted that information obtained via RTI from the directorate of blood Safety (on March 3) and the health department (on March 17) revealed that no progress had been made, and NAT-PCR testing remained limited to the same 11 centres.
"The govt made a commitment before this court and failed to act on it. This amounts to a deliberate and wilful violation of the court's order," Das said before the bench, appearing in person.
Taking note of the submissions, the bench asked the commissioner-cum-secretary to clarify what actions had been initiated since the court's directive and fixed the next hearing for Aug 4. In his original PIL, Das had highlighted the risks of transfusing infected blood due to the limitations of ELISA testing. He urged the court to ensure the implementation of NAT-PCR testing across all centres in a time-bound manner to ensure safer blood transfusion practices.
